Guest guest Posted August 29, 2007 Report Share Posted August 29, 2007 Alimentary Pharmacology & Therapeutics (OnlineAccepted Articles). doi:10.1111/j.1365-2036.2007.03498.x Abstract Alpha fetoprotein, ultrasound, CT and MRI for detection of hepatocellular carcinoma in patients with advanced cirrhosis N. SNOWBERGER11Department of Medicine, Baylor University Medical Center, S. CHINNAKOTLA2,32Department of Surgery, Baylor University Medical Center3Baylor Regional Transplant Institute, Dallas, Texas, USA., R. M. LEPE-SUASTEQUI1,31Department of Medicine, Baylor University Medical Center3Baylor Regional Transplant Institute, Dallas, Texas, USA., J. PEATTIE33Baylor Regional Transplant Institute, Dallas, Texas, USA., R. GOLDSTEIN2,32Department of Surgery, Baylor University Medical Center3Baylor Regional Transplant Institute, Dallas, Texas, USA., G. B. KLINTMALM2,32Department of Surgery, Baylor University Medical Center3Baylor Regional Transplant Institute, Dallas, Texas, USA. & G. L. DAVIS1,31Department of Medicine, Baylor University Medical Center3Baylor Regional Transplant Institute, Dallas, Texas, USA.1Department of Medicine, Baylor University Medical Center 2Department of Surgery, Baylor University Medical Center 3Baylor Regional Transplant Institute, Dallas, Texas, USA. Corresponding Author: G. L. DAVIS 4 , Hepatology Baylor University Medical Center 3500 Gaston Avenue Dallas, TX 75246 Phone: 214-820-1857 Fax: 214-820-8168 e-mail: garydav@... SUMMARY Background: Serum alpha fetoprotein (AFP), ultrasound, CT scanning, and MRI are commonly used to screen for hepatocellular carcinoma (HCC) in patients with cirrhosis. Aim: To assess the accuracy of screening in advanced cirrhosis. Methods: The study group was 239 patients with proven HCC in the explanted liver at the time of liver transplant (LTx). AFP and imaging were done at referral and serially until transplant. Results: HCC was detected before LTx in 78% and discovered incidentally in 22%. The cause of cirrhosis was HCV (55%), HBV (17%), alcohol (9%), and other/unknown (19%). Although AFP was elevated 62%, the median level was 15 ng/mL. Only 26%, 15% and 13% were more than 100, 400 and 1000 ng/mL, respectively. By comparison, AFP was elevated in 20% without HCC, but exceeded 100 ng/mL in only 3%. The overall accuracy of AFP was poor regardless of the cutoff. MRI was more accurate than CT or ultrasound in detecting tumor, particularly when performed within 3 months of transplant. Conclusions: MRI is most sensitive for imaging HCC and best reflects actual tumor size. AFP is insensitive and adds little to screening strategies, but has prognostic value when extremely elevated. http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2036.2007.03498.x _________________________________________________________________ Learn.Laugh.Share. Reallivemoms is right place! http://www.reallivemoms.com?ocid=TXT_TAGHM & loc=us Quote Link to comment Share on other sites More sharing options...
Guest guest Posted August 29, 2007 Report Share Posted August 29, 2007 Alimentary Pharmacology & Therapeutics (OnlineAccepted Articles). doi:10.1111/j.1365-2036.2007.03498.x Abstract Alpha fetoprotein, ultrasound, CT and MRI for detection of hepatocellular carcinoma in patients with advanced cirrhosis N. SNOWBERGER11Department of Medicine, Baylor University Medical Center, S. CHINNAKOTLA2,32Department of Surgery, Baylor University Medical Center3Baylor Regional Transplant Institute, Dallas, Texas, USA., R. M. LEPE-SUASTEQUI1,31Department of Medicine, Baylor University Medical Center3Baylor Regional Transplant Institute, Dallas, Texas, USA., J. PEATTIE33Baylor Regional Transplant Institute, Dallas, Texas, USA., R. GOLDSTEIN2,32Department of Surgery, Baylor University Medical Center3Baylor Regional Transplant Institute, Dallas, Texas, USA., G. B. KLINTMALM2,32Department of Surgery, Baylor University Medical Center3Baylor Regional Transplant Institute, Dallas, Texas, USA. & G. L. DAVIS1,31Department of Medicine, Baylor University Medical Center3Baylor Regional Transplant Institute, Dallas, Texas, USA.1Department of Medicine, Baylor University Medical Center 2Department of Surgery, Baylor University Medical Center 3Baylor Regional Transplant Institute, Dallas, Texas, USA. Corresponding Author: G. L. DAVIS 4 , Hepatology Baylor University Medical Center 3500 Gaston Avenue Dallas, TX 75246 Phone: 214-820-1857 Fax: 214-820-8168 e-mail: garydav@... SUMMARY Background: Serum alpha fetoprotein (AFP), ultrasound, CT scanning, and MRI are commonly used to screen for hepatocellular carcinoma (HCC) in patients with cirrhosis. Aim: To assess the accuracy of screening in advanced cirrhosis. Methods: The study group was 239 patients with proven HCC in the explanted liver at the time of liver transplant (LTx). AFP and imaging were done at referral and serially until transplant. Results: HCC was detected before LTx in 78% and discovered incidentally in 22%. The cause of cirrhosis was HCV (55%), HBV (17%), alcohol (9%), and other/unknown (19%). Although AFP was elevated 62%, the median level was 15 ng/mL. Only 26%, 15% and 13% were more than 100, 400 and 1000 ng/mL, respectively. By comparison, AFP was elevated in 20% without HCC, but exceeded 100 ng/mL in only 3%. The overall accuracy of AFP was poor regardless of the cutoff. MRI was more accurate than CT or ultrasound in detecting tumor, particularly when performed within 3 months of transplant. Conclusions: MRI is most sensitive for imaging HCC and best reflects actual tumor size. AFP is insensitive and adds little to screening strategies, but has prognostic value when extremely elevated. http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2036.2007.03498.x _________________________________________________________________ Learn.Laugh.Share. Reallivemoms is right place! http://www.reallivemoms.com?ocid=TXT_TAGHM & loc=us Quote Link to comment Share on other sites More sharing options...
Guest guest Posted August 29, 2007 Report Share Posted August 29, 2007 Alimentary Pharmacology & Therapeutics (OnlineAccepted Articles). doi:10.1111/j.1365-2036.2007.03498.x Abstract Alpha fetoprotein, ultrasound, CT and MRI for detection of hepatocellular carcinoma in patients with advanced cirrhosis N. SNOWBERGER11Department of Medicine, Baylor University Medical Center, S. CHINNAKOTLA2,32Department of Surgery, Baylor University Medical Center3Baylor Regional Transplant Institute, Dallas, Texas, USA., R. M. LEPE-SUASTEQUI1,31Department of Medicine, Baylor University Medical Center3Baylor Regional Transplant Institute, Dallas, Texas, USA., J. PEATTIE33Baylor Regional Transplant Institute, Dallas, Texas, USA., R. GOLDSTEIN2,32Department of Surgery, Baylor University Medical Center3Baylor Regional Transplant Institute, Dallas, Texas, USA., G. B. KLINTMALM2,32Department of Surgery, Baylor University Medical Center3Baylor Regional Transplant Institute, Dallas, Texas, USA. & G. L. DAVIS1,31Department of Medicine, Baylor University Medical Center3Baylor Regional Transplant Institute, Dallas, Texas, USA.1Department of Medicine, Baylor University Medical Center 2Department of Surgery, Baylor University Medical Center 3Baylor Regional Transplant Institute, Dallas, Texas, USA. Corresponding Author: G. L. DAVIS 4 , Hepatology Baylor University Medical Center 3500 Gaston Avenue Dallas, TX 75246 Phone: 214-820-1857 Fax: 214-820-8168 e-mail: garydav@... SUMMARY Background: Serum alpha fetoprotein (AFP), ultrasound, CT scanning, and MRI are commonly used to screen for hepatocellular carcinoma (HCC) in patients with cirrhosis. Aim: To assess the accuracy of screening in advanced cirrhosis. Methods: The study group was 239 patients with proven HCC in the explanted liver at the time of liver transplant (LTx). AFP and imaging were done at referral and serially until transplant. Results: HCC was detected before LTx in 78% and discovered incidentally in 22%. The cause of cirrhosis was HCV (55%), HBV (17%), alcohol (9%), and other/unknown (19%). Although AFP was elevated 62%, the median level was 15 ng/mL. Only 26%, 15% and 13% were more than 100, 400 and 1000 ng/mL, respectively. By comparison, AFP was elevated in 20% without HCC, but exceeded 100 ng/mL in only 3%. The overall accuracy of AFP was poor regardless of the cutoff. MRI was more accurate than CT or ultrasound in detecting tumor, particularly when performed within 3 months of transplant. Conclusions: MRI is most sensitive for imaging HCC and best reflects actual tumor size. AFP is insensitive and adds little to screening strategies, but has prognostic value when extremely elevated. http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2036.2007.03498.x _________________________________________________________________ Learn.Laugh.Share. Reallivemoms is right place! http://www.reallivemoms.com?ocid=TXT_TAGHM & loc=us Quote Link to comment Share on other sites More sharing options...
Guest guest Posted August 29, 2007 Report Share Posted August 29, 2007 Alimentary Pharmacology & Therapeutics (OnlineAccepted Articles). doi:10.1111/j.1365-2036.2007.03498.x Abstract Alpha fetoprotein, ultrasound, CT and MRI for detection of hepatocellular carcinoma in patients with advanced cirrhosis N. SNOWBERGER11Department of Medicine, Baylor University Medical Center, S. CHINNAKOTLA2,32Department of Surgery, Baylor University Medical Center3Baylor Regional Transplant Institute, Dallas, Texas, USA., R. M. LEPE-SUASTEQUI1,31Department of Medicine, Baylor University Medical Center3Baylor Regional Transplant Institute, Dallas, Texas, USA., J. PEATTIE33Baylor Regional Transplant Institute, Dallas, Texas, USA., R. GOLDSTEIN2,32Department of Surgery, Baylor University Medical Center3Baylor Regional Transplant Institute, Dallas, Texas, USA., G. B. KLINTMALM2,32Department of Surgery, Baylor University Medical Center3Baylor Regional Transplant Institute, Dallas, Texas, USA. & G. L. DAVIS1,31Department of Medicine, Baylor University Medical Center3Baylor Regional Transplant Institute, Dallas, Texas, USA.1Department of Medicine, Baylor University Medical Center 2Department of Surgery, Baylor University Medical Center 3Baylor Regional Transplant Institute, Dallas, Texas, USA. Corresponding Author: G. L. DAVIS 4 , Hepatology Baylor University Medical Center 3500 Gaston Avenue Dallas, TX 75246 Phone: 214-820-1857 Fax: 214-820-8168 e-mail: garydav@... SUMMARY Background: Serum alpha fetoprotein (AFP), ultrasound, CT scanning, and MRI are commonly used to screen for hepatocellular carcinoma (HCC) in patients with cirrhosis. Aim: To assess the accuracy of screening in advanced cirrhosis. Methods: The study group was 239 patients with proven HCC in the explanted liver at the time of liver transplant (LTx). AFP and imaging were done at referral and serially until transplant. Results: HCC was detected before LTx in 78% and discovered incidentally in 22%. The cause of cirrhosis was HCV (55%), HBV (17%), alcohol (9%), and other/unknown (19%). Although AFP was elevated 62%, the median level was 15 ng/mL. Only 26%, 15% and 13% were more than 100, 400 and 1000 ng/mL, respectively. By comparison, AFP was elevated in 20% without HCC, but exceeded 100 ng/mL in only 3%. The overall accuracy of AFP was poor regardless of the cutoff. MRI was more accurate than CT or ultrasound in detecting tumor, particularly when performed within 3 months of transplant. Conclusions: MRI is most sensitive for imaging HCC and best reflects actual tumor size. AFP is insensitive and adds little to screening strategies, but has prognostic value when extremely elevated. http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2036.2007.03498.x _________________________________________________________________ Learn.Laugh.Share. Reallivemoms is right place! http://www.reallivemoms.com?ocid=TXT_TAGHM & loc=us Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.